Free Trial

Twist Bioscience (TWST) Earnings Date, Estimates & Call Transcripts

Twist Bioscience logo
$56.70 +0.51 (+0.91%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$58.18 +1.48 (+2.60%)
As of 08:49 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Twist Bioscience Earnings Summary

Twist Bioscience announced Q2 2026 earnings on May 4, 2026, reporting an EPS of -$0.71, which missed analysts' consensus estimates of -$0.49 by $0.22. Quarterly revenue rose 19.3% year-over-year to $110.72 million, above the consensus estimate of $107.64 million. With a trailing EPS of -$1.33, Twist Bioscience's earnings are expected to grow next year, from ($1.86) to ($1.50) per share.

Latest Q2
Earnings Date
May. 4Estimated
Consensus EPS
(May. 4)
-$0.49
Actual EPS
(May. 4)
-$0.71 Missed By -$0.22
Actual Revenue
(May. 4)
$110.72M

Q2 2026 Earnings Resources

Get Twist Bioscience Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Twist Bioscience and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

TWST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TWST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Twist Bioscience Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20262-$0.47-$0.43-$0.45$100.4 M$100.0 M - $101.0 M
Q2 20262-$0.46-$0.45-$0.46$104.5 M$107.0 M - $108.0 M
Q3 20262-$0.38-$0.38-$0.38$111.3 M$114.0 M - $115.0 M
Q4 20262-$0.35-$0.34-$0.35
FY 2026 8 -$1.66 -$1.60 -$1.63
Q1 20271-$0.38-$0.38-$0.38
Q2 20271-$0.33-$0.33-$0.33
Q3 20271-$0.30-$0.30-$0.30
Q4 20271-$0.27-$0.27-$0.27

Twist Bioscience Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/4/2026Q2 2026-$0.49-$0.71 -$0.22-$0.71$107.64M$110.72M
2/2/2026Q1 2026-$0.48-$0.50 -$0.02-$0.50$100.32M$103.70M
11/14/2025Q4 2025-$0.40-$0.45 -$0.05-$0.45$97.40M$99.01M
8/4/2025Q3 2025-$0.54-$0.47+$0.07$0.33$95.52M$96.06M
5/5/2025Q2 2025-$0.56-$0.66 -$0.10-$0.66$92.00M$92.79M
2/3/2025Q1 2025-$0.62-$0.53+$0.09-$0.53$86.96M$88.70M
8/2/2024Q3 2024-$0.76-$1.47 -$0.71-$0.25$77.40M$81.50M

Data powered by Fiscal.ai.

Twist Bioscience Earnings - Frequently Asked Questions

Twist Bioscience (NASDAQ:TWST) last announced its quarterly earning data on Monday, May 4, 2026. Learn more on TWST's earnings history.

Twist Bioscience issued an update on its third quarter 2026 earnings guidance on Monday, May, 4th. The company issued revenue guidance of $114.0 million-$115.0 million, compared to the consensus revenue estimate of $111.3 million.

In the previous quarter, Twist Bioscience (NASDAQ:TWST) missed the analysts' consensus estimate of ($0.49) by $0.22 with a reported earnings per share (EPS) of ($0.71). Learn more on analysts' earnings estimate vs. TWST's actual earnings.

The conference call for Twist Bioscience's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Twist Bioscience's latest earnings report can be read online.
Read Transcript

Twist Bioscience (NASDAQ:TWST) has a recorded annual revenue of $376.57 million.

Twist Bioscience (NASDAQ:TWST) has a recorded net income of -$77.67 million. TWST has generated -$1.33 earnings per share over the last four quarters.

Twist Bioscience's earnings are expected to grow from ($1.86) per share to ($1.50) per share in the next year.


This page (NASDAQ:TWST) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners